Galactosamine-induced hepatotoxic effect and hepatoprotective role of a protein isolated from the herb Cajanus indicus L in vivo

Journal of Biochemical and Molecular Toxicology

Volumn 21, Issue 1, 2007, Pages 13-23

  Manna, Prasenjit ^a   Sinha, Mahua ^a   Sil, Parames C ^a  

^a BOSE INSTITUTE   (India)

Author keywords

43 kD Protein; Antioxidant; D(+) Galactosamine; Hepatoprotection; Hepatotoxicity; Oxidative Stress

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; BIOLOGICAL MARKER; CAJANUS INDICUS EXTRACT; CATALASE; GALACTOSAMINE; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; PLANT EXTRACT; PROTEIN; SUPEROXIDE DISMUTASE; THIOL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HERBAL MEDICINE; INTOXICATION; LIPID PEROXIDATION; LIVER PROTECTION; LIVER TOXICITY; MALE; MOLECULAR WEIGHT; MOUSE; NONHUMAN; OXIDATIVE STRESS; PLANT LEAF; PROTEIN ISOLATION; TREATMENT OUTCOME;

ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ANIMALS; BIOLOGICAL MARKERS; CAJANUS; CATALASE; GALACTOSAMINE; GLUTATHIONE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; HEPATITIS, TOXIC; LIPID PEROXIDATION; LIVER; MICE; PLANT PROTEINS; PROTECTIVE AGENTS; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

CAJANUS CAJAN; MUS;

EID: 34147136101     PISSN: 10956670     EISSN: 10990461     Source Type: Journal    
DOI: 10.1002/jbt.20154     Document Type: Article

References (63)

1. Keppler D, Decker K. Studies on the mechanism of galactosamine hepatitis: accumulation of galactosamine-1-phosphate and its inhibition of UDP glucose pyrophosphorylase. Eur J Biochem 1969;10:219-225.
2. Mangeney-Andreani M, Sire O, Montagne-Clavel J, Nordmann R, Nordmanna J. Inhibitory effect of D-galactosamine administration on fatty acid oxidation in rat hepatocytes. FEBS Lett 1982;145:267-270.
3. Keppler D, Pausch J, Decker K. Selective uridine triphosphate deficiency induced by D galactosamine in liver and reversed by pyrimidine nucleotide precursors. Effect on ribonucleic acid synthesis. J Biol Chem 1974;249:211-216.
4. El-Mofty SK, Scrutton MC, Serroni A, Nicolini C, Farber JL. Early reversible plasma membrane injury in galactosamine induced liver cell death. Am J Pathol 1975;79:579-595.
5. Han KH, Hashimoto N, Shimada K, Sekikawa M, Noda T, Yamauchi H, Hashimoto M, Chiji H, Topping D, Fukushima M. Hepatoprotective effect of purple potato extract against D galactosamine induced liver injury in rats. Biosci Biotechnol Biochem 2006;70:1432-1437.
6. Itokazu Y, Segawa Y, Inoue N, Omita T. D-galactosamine induced mouse hepatic apoptosis: Possible involvement with tumor necrosis factor, but not with caspase-3 activity. Biol Pharm Bull 1999;22:1127-1130.
7. Lim HK, Kim HS, Choi HS, Oh S, Jang CG, Choi J, Kim SH, Chang MJ. Effect of acetyl bergenin against D galactosamine induced hepatotoxicity in rats. Pharmacol Res 2000;42:471-474.
8. Sugiyama K, He P, Wada S, Saeki S. Teas and other beverages suppress D galactosamine induced liver injury in rats. J Nutr 1999;129:1361-1367.
9. Donatus IA, Sardjoko Vermeulen NP. Cytotoxic and cytoprotective activities of curcumin. Effects on paracetamol-induced cytotoxicity, lipid peroxidation and glutathione depletion in rat hepatocytes. Biochem Pharmacol 1990;39:1869-1875.
10. Farghali H, Kamenikova L, Hynie S, Kmonickova E. Silymarin effects on intracellular calcium and cytotoxicity: A study in perfused rat hepatocytes after oxidative stress injury. Pharmacol Res 2000;41:231-237.
11. Chrungoo VJ, Singh K, Singh I. Silymarin mediated differential modulation of toxicity induced by carbon tetrachloride, paracetamol and D-galactosamine in freshly isolated rat hepatocytes. Ind J Exp Biol 1997;35:611-617.
12. Chauhan CK, Nanivadekar SA, Billimoria, FR. Effect of a herbal hepatoprotective product on drug metabolism in patients of cirrhosis and hepatic enzyme function in experimental liver damage. Ind J Pharmacol 1992;24:107-110.
13. Syamasundar KV, Singh B, Thakur RS, Husain A, Kiso Y, Hikino H. Antihepatotoxic principles of Phyllanthus niruri herbs. J Ethnopharmacol 1985;14:41-44.
14. Venkateswaran PS, Millman I, Blumberg BS. Effects of an extract from Phyllanthus niruri on hepatitis B and woodchuck hepatitis viruses: in vitro and in vivo studies. Proc Natl Acad Sci USA 1987;84:274-278.
15. Unander DW, Webster GL, Blumberg BS. Usage and bioassays in Phyllanthus (Euphorbiaceae), IV: Clustering of antiviral uses and other effects. J Ethnopharmacol 1995;45:1-18.
16. Manna P, Sinha M, Sil PC. Aqueous extract of Terminalia arjuna prevents carbon tetracrdoride induced hepatic and renal disorders. BMC Complement Altern Med 2006;6:33.
17. Karthikeyan K, Sarala Bai BR, Gauthaman K, Sathish KS, Niranjali Devaraj S. Cardioprotective effect of the alcoholic extract of Terminalia arjuna bark in an in vivo model of myocardial ischemic reperfusion injury. Life Sci 2003;73:2727-2739.
18. Bharani A, Ganguly A, Bhargava KD. Salutary effect of Terminalia arjuna in patients with severe refractory heart failure. Int J Cardiol 1995;49:191-199.
19. Choudhuri BR, Poddar MK. Andrographolide and kalmegh (Andrographis paniculata) extract: in vivo and in vitro effect on hepatic lipid peroxidation. Methods Find Exp Clin Pharmacol 1984;6:481-485.
20. Ghosh A, Biswas K. In Chatterjee A, editor. Bhartiya banausadhi. Calcutta, India: Calcutta University Press; 1973. Vol 2, pp 332-334.
21. Kirtikar KR, Basu BD. In: Blatter E, Caius JF, Mhaskarr RS, editors; Indian medicinal plants; Calcutta, India: Probasi Press; 1935;Vol I, p 809.
22. Sarkar K, Ghosh A, Kinter A, Mazumder B, Sil PC. Purification and characterization of a 43-kD hepatoprotective protein from the herb Cajanus indicus L. Protein J; 2006;25:411-421.
23. Ghosh A, Sarkar K, Sil PC. Protective effect of a 43-kD protein from the leaves of the herb, Cajanus indicus L on chloroform induced hepatic-disorder. J Biochem Mol Biol 2006;39:197-207.
24. Ghosh A, Sil PC. A 43-kD protein from the leaves of the herb, Cajanus indicus L, modulates chloroform induced hepatotoxicity in vitro. Drug Chem Toxicol 2006;29:397-413.
25. Sarkar K, Sil PC. A 43-kDa protein from the herb Cajanus indicus L. protects thioacetamide induced cytotoxicity in hepatocytes. Toxicol in Vitro 2006;20:634-640.
26. Sarkar K, Ghosh A, Sil PC. Preventive and curative role of a 43-kD protein from the leaves of the herb Cajanus indicus L on thioacetamide induced hepatotoxicity in vivo. Hepatol Res 2005;33:39-49.
27. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
28. Reitman S, Frankel S. A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Am J Clin Pathol 1957;28:56-63.
29. Kind PRN, King EJ. Estimation of plasma phosphatase by determination of hydrolysed phenol with anti-pyrine. J Clin Pathol 1954;7:322-326.
30. Esterbauer H, Cheeseman, KH. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 1990;186:407-421.
31. Nishikimi M, Rao NA, Yagi K. The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen. Biochem Biophys Res Commun 1972;46:849-854.
32. Kakkar P, Das B, Viswanathan PN. A modified spectrophotometric assay of Superoxide dismutase. Ind J Biochem Biophys 1984;21:130-132.
33. Bonaventura J, Schroeder WA, Fang S. Human erythrocyte catalase: An improved method of isolation and a revaluation of reported properties. Arch Biochem Biophys 1972;150:606-617.
34. Habig WH, Jakoby WB. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 1974;249:7130-7139.
35. Smith IK, Vierheller TL, Thorne CA. Assay of glutathione reductase in crude tissue homogenates using 5,5′-dithiobis(2-nitrobenzoic acid). Anal Biochem 1988;175:408-413.
36. Ellman GL. Tissue sulfhydryl group. Arch Biochem Biophys 1959;82:70-77.
37. Hissin PJ, Hilf RA. A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem 1976;74:214-226.
38. Sedlak J, Lindsay RH. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem 1958;24/25:192-205.
39. Muntane J, Rodriguez FJ, Segado O, Quintero A, Lozano JM, Siendones E, Pedraza CA, Delgado M, O'Valle F, Garcia R, Montero JL, De La Mata M, Mino G. TNFα-dependant production of inducible nitric oxide is involved in PGE1 protection against acute liver injury. Gut 2000;47:553-562.
40. Quintero A, Pedraza CA, Siendones E, Kamal Elsaid AM, Colell A, Garcia Ruiz C, Montero JL, De La Mata M, Fernandez-Checa JC, Mino G, Muntane J. PGEl protection against apoptosis induced by D galactosamine is not related to the modulation of intracellular free radical production in primary culture rat hepatocytes. Free Radic Res 2002;36:345-355.
41. Dalle-Donne I, Giustarini D, Colombo R, Rossi R, Milzani A. Protein carbonylation in human diseases. Trends Mol Med 2003;9:169-176.
42. Dukan S, Nyström T. Oxidative stress defense and deterioration of growth arrested Escherichia coli cells. J Biol Chem 1999;274:26027-26032.
43. MacMillan-Crow LA, Crow JP, Thompson JA. Peroxynitrite-mediated inactivation of manganese superoxide dismutase involves nitration and oxidation of critical tyrosine residues. Biochemistry 1998;37:1613-1622.
44. 2 by yeast. J Biol Chem 2004;279:35219-35227.
45. Diazo A, Egashira Y, Sananda H. Suppressive effect of corn bran hemicellulose on liver induced by D galactosamine in rats. Nutrition 2005;21:1044-1051.
46. Hu HL, Chen RD. Changes in free radicals trace elements and neurophysiological function in rats with liver damage induced by D galactosamine. Biol Trace Elem Res 1992;34:19-25.
47. Gyamfi MA, Yonamine M, Aniya Y. Free radical scavenging action of medicinal herbs from Ghana: Thonningia sanguinea on experimentally induced liver injuries. Gene Pharmacol 1999;32:661-667.
48. Oh PS, Lee SJ, Lim KT. Hypolipidemic and antioxidative effects of the plant glycoprotein (36 kDa) from Rhus verniciflua stokes fruit in triton WR-1339-induced hyperlipidemic mice. Biosci Biotechnol Biochem 2006;70:447-456.
49. Lee SJ, Oh PS, Ko JH, Lim K, Lim KT. Protective effect of glycoprotein isolated from Ulmus davidiana Nakai on carbon tetrachloride-induced mouse liver injury. J Pharm Pharmacol 2006;58:143-152.
50. Tsoi AY, Ng TB, Fong WP. Antioxidative effect of a chymotrypsin inhibitor from Momordica cochinchinesis (Cucurbitaceae) seeds in primary rat hepatocyte culture. J Pep Sci 2005;11:665-668.
51. Bruck R, Aeed H, Schey R, Matas Z, Reifen R, Zaiqer G, Hochman A, Avni Y. Pyrrolidine dithiocarbamate protects against thioacetamide-induced fulminant hepatic failure in rats. J Hepatol 2002;36:370-377.
52. Lu SC, Huang ZZ, Yang H, Tsukamoto H. Effect of thioacetamide on the hepatic expression of gamma-glutamylcysteine synthetase subunits in the rat. Toxicol Appl Pharmacol 1999;159:161-168.
53. Muller D, Sommer M, Kretzschmar M, Zimmermann T, Buko VU, Lukivskaya O, Darqel R. Lipid peroxidation in thioacetamide induced macronodular rat liver cirrhosis. Arch Toxicol 1991;65:199-203.
54. Schreck R, Albermann K, Baeuerle PA. Nuclear factor kappa B: An oxidative stress-responsive transcription factor of eukaryotic cells. Free Radie Res Commun 1992;17:221-237.
55. Bruck R, Aeed H, Avni Y, Shirin H, Matas Z, Shahmurov M, Avinnoach I, Zozulya G, Weizman N, Hochman A. Melatonin inhibits nuclear factor kappa B activation and oxidative stress and protects against thioacetamide induced liver damage in rats. J Hepatol 2004;40:86-93.
56. Lv P, Luo HS, Zhou XP, Chireyath Paul S, Xiao YJ, Si XM, Liu SQ. Thalidomide prevents rat liver cirrhosis via inhibition of oxidative stress. Pathol Res Pract 2006;202:777-788.
57. Kim SK, Abdelmegeed MA, Novak RF. The mitogen-activated protein kinase kinase (MEK) inhibitor PD98059 elevates primary cultured rat hepatocyte glutathione levels independent of inhibiting MEK. Drug Metab Dispos 2006;34:683-689.
58. Alexia C, Fourmatgeat P, Delautier D, Groyer A. Insulin-like growth factor-I stimulates H4II rat hepatoma cell proliferation: Dominant role of PI-3′K/Akt signaling. Exp Cell Res 2006;312:1142-1152.
59. Coutant A, Rescan C, Gilot D, Loyer P, Guguen-Guillouzo C, Baffet G. PI3K-FRAP/mTOR pathway is critical for hepatocyte proliferation whereas MEK/ERK supports both proliferation and survival. Hepatology 2002;36:1079-1088.
60. Hoffer A, Chang CY, Puga A. Dioxin induces transcription of fos and jun genes by Ah receptor-dependent and -independent pathways. Toxicol Appl Pharmacol 1996;141:238-247.
61. Tugendreich S, Pearson CI, Sagartz J, Jarnagin K, Kolaja K. NSAID-induced acute phase response is due to increased intestinal permeability and characterized by early and consistent alterations in hepatic gene expression. Toxicol Pathol 2006;34:168-179.
62. Pan H, Hong F, Radaeva S, Gao B. Hydrodynamic gene delivery of interleukin-22 protects the mouse liver from concanavalin A-, carbon tetrachloride-, and Fas ligand-induced injury via activation of STATS. Cell Mol Immunol 2004;1:43-49.
63. Klein C, Wustefeld T, Assmus U, Roskams T, Rose-John S, Muller M, Manns MD, Ernst M, Trautwein C. The IL-6-gp130-STAT3 pathway in hepatocytes triggers liver protection in T cell-mediated liver injury. J Clin Invest 2005;115:860-869.